AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $484,329 | +0.4% | 17,102 | -18.6% | 0.00% | 0.0% |
| Q1 2023 | $482,462 | -54.4% | 21,004 | -44.3% | 0.00% | -50.0% |
| Q4 2022 | $1,058,756 | -52.4% | 37,705 | -52.0% | 0.00% | -50.0% |
| Q3 2022 | $2,223,000 | -36.4% | 78,602 | -50.1% | 0.00% | +33.3% |
| Q2 2022 | $3,493,000 | +3.2% | 157,531 | +156.6% | 0.00% | 0.0% |
| Q2 2021 | $3,384,000 | +24.1% | 61,400 | +20.4% | 0.00% | 0.0% |
| Q2 2020 | $2,727,000 | +833.9% | 50,988 | +518.6% | 0.00% | – |
| Q1 2020 | $292,000 | +90.8% | 8,243 | +316.7% | 0.00% | – |
| Q3 2018 | $153,000 | -91.3% | 1,978 | -90.5% | 0.00% | -100.0% |
| Q2 2018 | $1,751,000 | -14.6% | 20,784 | -32.4% | 0.00% | -33.3% |
| Q3 2017 | $2,051,000 | – | 30,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |